Randomized open-label non-inferiority trial of paracetamol or celecoxib for patients with chronic low back pain
Authors:
Open Access
- 9 December 2025
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 16 (1)
Abstract
Pharmacological treatment is commonly used for patients with chronic low back pain (CLBP). However, very low-quality evidence exists for paracetamol as a treatment option for CLBP; therefore, recommendations are contradictory among the guidelines. This randomized controlled study aimed to compare the analgesic effects of paracetamol and celecoxib in a non-inferiority trial. This non-inferiority trial tested the hypothesis that paracetamol is as effective as celecoxib for the treatment of CLBP within a pre-specified non-inferiority margin. One hundred fifty-six patients with CLBP were considered eligible and randomly allocated to a group receiving paracetamol or celecoxib. The pain intensity was measured using a numerical rating scale as the primary outcome. Secondary outcomes were pain-related psychological variables, quality of life, and adverse events. One hundred thirty-nine patients completed the study (paracetamol, 70; celecoxib, 69). We observed that the mean differences in the NRS changes between the two medication groups from baseline to weeks two and four did not significantly exceed the non-inferiority margin. Paracetamol had a superior effect on pain-related psychological variables and quality of life compared to celecoxib. These results suggest that paracetamol provides analgesic effects comparable to celecoxib for CLBP, meeting the criteria for non-inferiority.Keywords
This publication has 29 references indexed in Scilit:
- Prevalence, Incidence, and Factors Associated With Non-Specific Chronic Low Back Pain in Community-Dwelling Older Adults Aged 60 Years and Older: A Systematic Review and Meta-AnalysisThe Journal of Pain, 2022
- Clinical practice guidelines for the management of non-specific low back pain in primary care: an updated overviewEuropean Spine Journal, 2018
- Prevention and treatment of low back pain: evidence, challenges, and promising directionsThe Lancet, 2018
- Randomized open-labbel non-inferiority trial of acetaminophen or loxoprofen for patients with acute low back painJournal of Orthopaedic Science, 2018
- Clinical practice guidelines for the noninvasive management of low back pain: A systematic review by the Ontario Protocol for Traffic Injury Management (OPTIMa) CollaborationEuropean journal of pain, 2016
- Clinical Efficacy of Celecoxib Compared to Acetaminophen in Chronic Nonspecific Low Back Pain: Results of a Randomized Controlled TrialArthritis Care & Research, 2016
- Understanding Equivalence and Noninferiority TestingJournal of General Internal Medicine, 2010
- Gastrointestinal Safety of Cyclooxygenase-2 Inhibitors: A Cochrane Collaboration Systematic ReviewClinical Gastroenterology and Hepatology, 2007
- Efficacy of Rofecoxib, Celecoxib, and Acetaminophen in Osteoarthritis of the KneeJAMA, 2002
- Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid ArthritisJAMA, 2000